Skip to content

Testing the Effect of KnowMAP (Knowledge Management for Renal Transplant Recipients). A Randomized Controlled Study

Testing the Effect of a New Health Communication Intervention for Renal Transplant Recipients (KnowMAP).

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04296955
Acronym
KnowMAP
Enrollment
200
Registered
2020-03-05
Start date
2020-03-09
Completion date
2025-10-31
Last updated
2025-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation

Keywords

health literacy, motivational interview, adherence, organ transplantation

Brief summary

A randomized controlled study (RCT) aiming to test the effect of a new health literacy intervention for renal transplant recipients, KnowMAP (knowledge management for renal transplant recipients).

Detailed description

Every year about 250-300 kidney transplantations are performed at Oslo University Hospital in Norway. Considerable improvements have recently emerged within kidney transplantation in relation to survival and quality of life. However, after transplantation, adherence to immunosuppressive drug therapy and other medical advices is crucial for staying healthy, keeping the graft, and retain good quality of life. In case of graft loss the patient has to return to dialysis, representing reduced functioning, fatigue and negative impact on quality of life. Dialysis also leads to higher costs for the society and in many cases a need for re-transplantation. A key challenge to adherence is the ability to gain access to, understand and use health information, defined as health literacy by the WHO. For renal transplant recipients preparedness for handling information and going through transplantation is essential. Hence, supporting the patients becoming reflective and health literate knowledge users is crucial. Through a RCT this project aims to test the effect of a new health communication intervention, KnowMAP (knowledge management for renal transplant recipients), as compared with standard care in patients undergoing renal transplantation. KnowMap is a novel intervention designed by clinicians and researchers at Oslo University Hospital (OUS), University of Oslo (UiO) and University of Stavanger (UiS). The intervention is targeting knowledge management skills of patients by using motivational interview (MI) techniques. It represents 4 sessions of individual patient counselling starting the first week after the transplantation.

Interventions

OTHERMotivational interview as a new health communication intervention

Same as intervention name

Sponsors

Helse Sor-Ost
CollaboratorOTHER_GOV
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Block randomization

Intervention model description

Interventional study model: Parallel assignment. 2- arm un-blinded RCT design. The arms are: 1. The intervention: 4 individual patient counseling sessions using adapted motivational interviewing techniques in addition to usual care. 2. Usual care: patients undergo standard patient education program for renal transplant recipients at OUS.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Kidney transplanted patients \> 18 years included within few days after kidney transplantation at Oslo University Hospital * Able to speak and understand Norwegian

Exclusion criteria

* Not able to speak or understand Norwegian well enough to be able to fill out forms or have a conversation in Norwegian. * Kidney transplanted patient \<18 years

Design outcomes

Primary

MeasureTime frameDescription
Health literacy (HL)24 months post transplantationHL measured by the HLQ (Health Literacy Questionnaire): The HLQ includes 44 items over nine independent scales, each representing a different element of the overall HL construct. Each scale includes 4-6 items. The first five scales comprise items asking the respondents to indicate level of agreement \[ranging from strongly disagree to strongly agree (range 1-4)\]. The remaining scales (6-9) have domains of self-reported capability (range 1-5: 'cannot do' to 'very easy'). The questionnaire has no total score, as that could potentially mask individual needs in specific HL domains. The HLQ appears robust for its intended purpose of assessing HL in a range of settings and has shown excellent reliability.
Adherence to immunosuppressive medication24 months post transplantationThe instrument BAASIS (The BAsel Adherence to immunoSuppressIve medication Scale) a self reporting adherence questionnaire measuring patients' taking, skipping, timing (\>2 hrs from prescribed time) and dose reduction of drugs. The recall period is limited to four weeks. The BAASIS comprises four questions with a 6-point scale for responses ranging from never (0) to every day (5)

Secondary

MeasureTime frameDescription
Quality of life and cost-effectiveness estimates relevant to this clinical context24 months post transplantationusing EQ-5D-5L, introduced by EuroQoL in 2009. It is a two pages, standardized generic questionnaire.
Knowledge24 months post transplantationUsing a Norwegian developed questionnaire: The Transplantation Knowledge Questionnaire
Occations of graft loss24 months post transplantationRegistred in the Norwegian Renal Registry (NNR)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026